
Jennifer Castro
Board member and Co-founder
About
19+ years of experience advancing multiple oncology precision medicine programs from target validation through IND and into early clinical development: · First-in-class DHX9 inhibitor, ATX-559 for molecularly defined solid tumors in Phase 1 (Project leader, Accent)· FDA-approved REZLIDHIA (Oluastenib, IDH1 mutant inhibitor) for relapsed/refractory AML (Forma) · CBP/p300 inhibitor Pocenbrodib (FT-7051) currently in Phase 2 for metastatic CRPC (Forma) · FT-4101 a FASN inhibitor, discontinued in Phase 1 for treatment of NASH (Forma) · FGFR inhibitor Derazanitinib currently in Phase 2 for intrahepatic cholangiocarcinoma (Arqule) Excels at cross-functional project leadership, driving translational and clinical assay development and strategy, building high impact partnerships across industry and academia, and contributing to the broader scientific community.
United States
Billerica
Biotechnology
Target Validation, Clinical Trials, People Management, Project Leadership, Collaborative Leadership, Networking, Webinar Management, Epigenetics, Angiogenesis, Translational Research, Drug Discovery, Biomarker Discovery, Oncology, Molecular Biology, Cell Biology, Assay Development, Drug Development, Cell, Cell Culture, Biotechnology
Experience

Board member and Co-founder
Boston Epigenetics Society
Boston, Massachusetts, United States

Research Scientist II
ArQule
Woburn, Massachusetts, United States

Research Assistant III
Tufts-New England Medical Center
Molecular Cardiology Research Center
Jennifer Castro's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles

Find Emails
Access verified email addresses for your target contacts.
657M+ emails

Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers

More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.






